跳到正文

KLRS — Kalaris Therapeutics Inc 机构持仓 · 2026年Q2

谁持有 Kalaris Therapeutics Inc(KLRS)?2026年Q2(报告期截至 2026-06-30)共有 65 家机构在 SEC 13F 申报中报告持有,合计 7,338.53 万美元。前几大持有机构:Samsara Biocapital, LLC(5,240.00 万美元)、Rtw Investments, LP(530.00 万美元)、Alyeska Investment Group, L.P.(230.00 万美元)。

排名机构市值股数变动
1SAMSARA BIOCAPITAL, LLC$52.4M12.9M减持
2RTW INVESTMENTS, LP$5.3M1.3M持平
3Alyeska Investment Group, L.P.$2.3M572,687持平
4VANGUARD GROUP INC$1.9M465,616增持
5Siren, L.L.C.$1.8M435,798持平
6Ikarian Capital, LLC$1.5M360,000持平
7UBS Group AG$1.1M262,131增持
8RENAISSANCE TECHNOLOGIES LLC$607,859149,351增持
9MARSHALL WACE, LLP$566,549139,201增持
10GEODE CAPITAL MANAGEMENT, LLC$464,287114,037增持
11Woodline Partners LP$407,000100,000持平
12ADAR1 Capital Management, LLC$407,000100,000持平
13WHI TRUST Co LLC$396,79797,493持平
14RAYMOND JAMES FINANCIAL INC$395,45797,164减持
15CITADEL ADVISORS LLC$389,79295,772新建仓
16BOOTHBAY FUND MANAGEMENT, LLC$375,50292,261持平
17Verdad Advisers, LP$326,80980,297新建仓
18MORGAN STANLEY$294,36772,326增持
19BlackRock, Inc.$221,58054,442增持
20Belpointe Asset Management LLC$162,80040,000持平
21Fortis Capital Advisors, LLC$162,80040,000持平
22Pale Fire Capital SE$161,27839,626新建仓
23Squarepoint Ops LLC$157,81438,775减持
24BRIDGEWAY CAPITAL MANAGEMENT, LLC$132,27532,500增持
25Stonepine Capital Management, LLC$122,59730,122增持

来源:SEC 13F 申报文件 · 截至 2026-06-30